<DOC>
	<DOCNO>NCT00525668</DOCNO>
	<brief_summary>Hypothesis : Sunphenon , green tea extract contain 95 % egcg , give daily oral medication period 18 month anti-inflammatory neuroprotective property patient relapsing-remitting multiple sclerosis assess magnetic resonance image clinical examination ( EDSS MSFC ) .</brief_summary>
	<brief_title>Sunphenon Epigallocatechin-gallate ( EGCg ) Relapsing-remitting Multiple Sclerosis ( SuniMS Study )</brief_title>
	<detailed_description>This multicentric , national study investigate efficacy safety EGCG patient relapsing-remitting multiple sclerosis .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<mesh_term>Epigallocatechin gallate</mesh_term>
	<criteria>male female subject age 18 60 relapsingremitting course MS stable treatment glatiramer acetate least 6 month prior inclusion primary secondary progressive form MS clinically relevant heart , lung , liver , kidney disease regular hepatotoxic comedication drug addiction alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>inflammation</keyword>
	<keyword>neurodegeneration</keyword>
	<keyword>neuroprotection</keyword>
</DOC>